Crown Bioscience is a Contract Research Organization (CRO) that specializes in translational oncology and immuno-oncology drug discovery and development. The company provides preclinical and translational services to biotech and pharmaceutical companies, enabling them to advance their research and development of cancer treatments. Crown Bioscience offers a range of services, including patient-derived xenograft (PDX) models, organoid models, and other preclinical models, as well as bioanalysis, biomarker discovery, and clinical trial support. The company's goal is to help its clients remove the guesswork from their research and development by providing high-quality, clinically relevant data and innovative solutions. Crown Bioscience also offers specialized services, such as 3D bone marrow models, to support the development of hematological cancer treatments. Overall, Crown Bioscience is a comprehensive CRO that supports the entire drug development process, from early discovery to clinical trials.